» Articles » PMID: 18653481

Role of the Kidney in Iron Homeostasis: Renal Expression of Prohepcidin, Ferroportin, and DMT1 in Anemic Mice

Overview
Specialties Nephrology
Physiology
Date 2008 Jul 26
PMID 18653481
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

It is known that renal tissue plays a role in normal iron homeostasis. The current study examines kidney function in iron metabolism under hemolytic anemia studying renal expression of Prohepcidin, Ferroportin (MTP1), and divalent metal transporter 1 (DMT1). The relationship between these proteins and iron pigments was also investigated. Immunohistochemical procedures to study renal expression of Prohepcidin, MTP1, and DMT1 were performed in healthy and anemic mice. Renal tissue iron was determined by Prussian blue iron staining. To assess anemia evolution and erythropoietic recovery, we used conventional tests. In healthy mice, Prohepcidin expression was marked in proximal tubules and inner medulla and absent in outer medulla. Cortical tissue of healthy mice also showed MTP1 immunostaining, mainly in the S2 segment of proximal tubules. Medullar tissue showed MTP1 expression in the inner zone. In addition, S2 segments showed intense DMT1 immunoreactivity with homogeneous DMT1 distribution throughout renal medulla. The main cortical findings in hemolytic anemia were in S2 segments of proximal tubules where we found that decreased Prohepcidin expression coincided with an increment in Ferroportin and DMT1 expression. This expression pattern was concomitant with increased iron in the same tubular zone. However, in medullar tissue both Prohepcidin and MTP1 decreased and DMT1 was detected mainly in larger diameter tubules. Our findings clearly demonstrate that in hemolytic anemia, renal Prohepcidin acts in coordination with renal Ferroportin and DMT1, indicating the key involvement of kidney in iron homeostasis when iron demand is high. Further research is required to learn more about these regulatory mechanisms.

Citing Articles

Advances of Iron and Ferroptosis in Diabetic Kidney Disease.

Chu J, Wang K, Lu L, Zhao H, Hu J, Xiao W Kidney Int Rep. 2024; 9(7):1972-1985.

PMID: 39081773 PMC: 11284386. DOI: 10.1016/j.ekir.2024.04.012.


Induction of Hepcidin Expression in the Renal Cortex of Sickle Cell Disease Mice.

Ahmad A, Kumari N, Afangbedji N, Nekhai S, Jerebtsova M Int J Mol Sci. 2023; 24(13).

PMID: 37445980 PMC: 10341858. DOI: 10.3390/ijms241310806.


Metals and Metallothionein Expression in Relation to Progression of Chronic Kidney Disease of Unknown Etiology (CKDu) in Sri Lanka.

Gunawickrama S, Silva A, Nanayakkara P, Gunawickrama K, Jayasekara J, Chandrasekharan N Diseases. 2022; 10(2).

PMID: 35735634 PMC: 9221887. DOI: 10.3390/diseases10020034.


The Macrophage Iron Signature in Health and Disease.

Mertens C, Marques O, Horvat N, Simonetti M, Muckenthaler M, Jung M Int J Mol Sci. 2021; 22(16).

PMID: 34445160 PMC: 8395084. DOI: 10.3390/ijms22168457.


The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload.

Mohammad G, Matakidou A, Robbins P, Lakhal-Littleton S Kidney Int. 2021; 100(3):559-569.

PMID: 33991530 PMC: 8456337. DOI: 10.1016/j.kint.2021.04.034.